Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ER. Am J Respir Crit Care Med. 1999 Aug;160(2):736-755. PMID: 10430755
Baltzan M, Mehta S, Kirkham TH, et al. Randomized trial of prolonged chloroquine therapy in advanced pulmonary sarcoidosis. Am J Respir Crit Care Med. 1999 Jul;160(1):192-197. PMID: 10390399
Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax. 1999 Aug;54(8):742-746. PMID: 10413729
British Thoracic Society. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction. Thorax. 1999 Apr;54(Suppl 1):S1-S14. PMID: 11006787
du Bois RM, Greenhalgh PM, Southcott AM, et al. Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: a pilot study. Eur Respir J. 1999 Jun;13(6):1345-1350. PMID: 10445610
Gibson GJ. Sarcoidosis: old and new treatments. Thorax. 2001 May;56(5):336-339. PMID: 11312398
Johns CJ, Michele TM. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore). 1999 Mar;78(2):65-111. PMID: 10195091
Milman N. Oral and inhaled corticosteroids in the treatment of pulmonary sarcoidosis-a critical reappraisal. Sarcoidosis Vasc Diffuse Lung Dis. 1998 Sep;15(2):150-157. PMID: 9789893
Morey SS. American Thoracic Society issues consensus statement on sarcoidosis. Am Fam Physician. 2000 Jan;61(2):553-556. PMID: 10670511
Judson MA. An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment. Chest. 1999 Apr;115(4):1158-1165. PMID: 10208222
Paramothayan NS, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA. 2002 Mar;287(10):1301-1307. PMID: 11886322
Paramothayan NS, Jones PW. Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev. 2000(4):CD001114. PMID: 11034698
Pacheco Y, Marechal C, Marechal F, et al. Azathioprine treatment of chronic pulmonary sarcoidosis. Sarcoidosis. 1985 Sep;2(2):107-113. PMID: 3031790
Pietinalho A, Tukiainen P, Haahtela T, et al. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group. Chest. 1999 Aug;116(2):424-431. PMID: 10453872
Pietinalho A, Tukiainen P, Haahtela T, et al. Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest. 2002 Jan;121(1):24-31. PMID: 11796428
Paramothayan S, Lasserson T, Walters EH. Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. Cochrane Database Syst Rev. 2003(3):CD003536. PMID: 12917971
Wu JJ, Schiff KR. Sarcoidosis. Am Fam Physician. 2004 Jul;70(2):312-322. PMID: 15291090
Cremers JP, Drent M, Bast A, et al. Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide. Curr Opin Pulm Med. 2013 Sep;19(5):545-561. http://www.wasog.org/PDFs/Cremers-MTX-2013.pdf. PMID: 23880702
Drent M, Cremers JP, Jansen TL, Baughman RP. Practical eminence and experience-based recommendations for use of TNF-aplha inhibitors in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(2):91-107. http://www.ildcare.nl/wp-content/uploads/2014/06/PS-AC-h7.pdf. Accessed 6 Aug 2014. PMID: 25078637
Jara-Palomares L, Caballero-Eraso C, Diaz-Baquero A, Rodriguez-Portal JA. Updated guidelines for the treatment of pulmonary sarcoidosis. Sarcoidosis diagnosis and management. Croatia: InTech; 2011. Accessed 6 Aug 2014.
